HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel point mutation (G-1 to T) in a 5' splice donor site of intron 13 of the dystrophin gene results in exon skipping and is responsible for Becker muscular dystrophy.

Abstract
The mutations in one-third of Duchenne and Becker muscular dystrophy patients remain unknown, as they do not involve gross rearrangements of the dystrophin gene. We now report a defect in the splicing of precursor mRNA (pre-mRNA), resulting from a maternally inherited mutation of the dystrophin gene in a patient with Becker muscular dystrophy. This defect results from a G-to-T transversion at the terminal nucleotide of exon 13, within the 5' splice site of intron 13, and causes complete skipping of exon 13 during processing of dystrophin pre-mRNA. The predicted polypeptide encoded by the aberrant mRNA is a truncated dystrophin lacking 40 amino acids from the amino-proximal end of the rod domain. This is the first report of an intraexon point mutation that completely inactivates a 5' splice donor site in dystrophin pre-mRNA. Analysis of the genomic context of the G-1-to-T mutation at the 5' splice site supports the exon-definition model of pre-mRNA splicing and contributes to the understanding of splice-site selection.
AuthorsY Hagiwara, H Nishio, Y Kitoh, Y Takeshima, N Narita, H Wada, M Yokoyama, H Nakamura, M Matsuo
JournalAmerican journal of human genetics (Am J Hum Genet) Vol. 54 Issue 1 Pg. 53-61 (Jan 1994) ISSN: 0002-9297 [Print] United States
PMID8279470 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • DNA Primers
  • Dystrophin
  • RNA Precursors
  • RNA, Messenger
Topics
  • Adult
  • Base Sequence
  • DNA Primers
  • Dystrophin (genetics)
  • Exons
  • Humans
  • Introns
  • Male
  • Molecular Sequence Data
  • Muscular Dystrophies (genetics)
  • Point Mutation
  • RNA Precursors (genetics)
  • RNA Splicing
  • RNA, Messenger (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: